WASHINGTON (Reuters) - U.S. regulators will allow experimental use of Insmed’s drug Iplex for certain patients with Lou Gehrig’s disease, the Food and Drug Administration said on Tuesday.
WASHINGTON (Reuters) - U.S. regulators will allow experimental use of Insmed’s drug Iplex for certain patients with Lou Gehrig’s disease, the Food and Drug Administration said on Tuesday.
